Stephens Inc. AR Increases Holdings in MetLife, Inc. (NYSE:MET)

Stephens Inc. AR grew its position in shares of MetLife, Inc. (NYSE:METFree Report) by 5.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 38,720 shares of the financial services provider’s stock after purchasing an additional 1,907 shares during the period. Stephens Inc. AR’s holdings in MetLife were worth $3,170,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in MET. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of MetLife by 1.5% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB grew its stake in MetLife by 16.8% during the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after purchasing an additional 608,224 shares in the last quarter. Swedbank AB boosted its stake in shares of MetLife by 76.0% during the 4th quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after buying an additional 1,496,645 shares during the last quarter. Jennison Associates LLC grew its position in shares of MetLife by 3.6% during the fourth quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock worth $268,096,000 after buying an additional 114,166 shares in the last quarter. Finally, Stifel Financial Corp grew its position in shares of MetLife by 5.0% during the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock worth $184,744,000 after buying an additional 105,762 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.

MetLife Stock Up 0.2 %

Shares of MetLife stock opened at $83.24 on Wednesday. The company has a market capitalization of $57.64 billion, a P/E ratio of 13.94, a PEG ratio of 0.64 and a beta of 1.07. The business’s fifty day moving average price is $83.64 and its two-hundred day moving average price is $80.93. MetLife, Inc. has a 1-year low of $67.04 and a 1-year high of $89.05. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16.

MetLife (NYSE:METGet Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, research analysts forecast that MetLife, Inc. will post 9.63 EPS for the current year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.62%. MetLife’s dividend payout ratio (DPR) is presently 36.52%.

Analyst Ratings Changes

Several research analysts have weighed in on MET shares. JPMorgan Chase & Co. raised their price objective on shares of MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. TD Cowen lifted their price target on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a report on Wednesday, November 27th. Wells Fargo & Company dropped their price objective on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. BMO Capital Markets assumed coverage on MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price for the company. Finally, StockNews.com cut MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, MetLife has a consensus rating of “Moderate Buy” and an average target price of $91.08.

Read Our Latest Stock Analysis on MetLife

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.